I Podcasten om inflammatorisk tarmsygdom får du værdifulde kliniske indsigter og praktiske værktøjer til både diagnose og patientkommunikaiton. Lyt med når læger, forskere og patienter deler deres perspektiver og erfaringer med behandling af inflammatorisk tarmsygdom i Danmark.
CP-505956
Referencer:
Nm. Noor et al. A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn’s disease (PROFILE): a multicentre, open-label randomised controlled trial. Lancet 2024; 9:415-427
D´Haens, G et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet. 2008; 371: 660-667
CP-489085
Referencer:
Christensen Risager, K, et al. A systematic monitoring approach to biologic therapies in inflammatory bowel disease: patients' and physicians' preferences and adherence. Scand J Gastroenterol. 2022 Mar;57(3):274281.doi:10.1080/00365521.2021.2002397.
Maaser Christian et al. Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study. Gut. 2020 Sep;69(9):1629-1636. doi: 10.1136/gutjnl-2019-319451.
Sagami S, et al. Early improvement in bowel wall thickness on transperineal ultrasonography predicts treatment success in active ulcerative colitis. Aliment Pharmacol Ther. 2022 May;55(10):1320-1329. doi: 10.1111/apt.16817. Epub 2022 Feb 25.
Flanagan E, et al. Monitoring Inflammatory Bowel Disease in Pregnancy Using Gastrointestinal Ultrasonography. J Crohns Colitis. 2020;14:1405–1412. doi: 10.1093/ecco-jcc/jjaa082.
De Voogd F et al. Intestinal Ultrasound to Evaluate Treatment Response During Pregnancy in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Dis. 2022;28:1045–1052. doi: 10.1093/ibd/izab216.
CP-480000